Profile data is unavailable for this security.
About the company
Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
- Revenue in AUD (TTM)2.24bn
- Net income in AUD356.80m
- Incorporated1983
- Employees5.00k
- LocationCochlear Ltd1 University AvenueMacquarie UniversitySYDNEY 2109AustraliaAUS
- Phone+61 29428-6555
- Fax+61 29428-6352
- Websitehttps://www.cochlear.com/sg/en/home
Mergers & acquisitions
| Acquired company | COH:ASX since announced | Transaction value |
|---|---|---|
| Neurelec SA | -7.88% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cochlear Ltd | 2.24bn | 356.80m | 19.52bn | 5.00k | 54.93 | 10.61 | 44.20 | 8.73 | 5.43 | 5.43 | 34.02 | 28.10 | 0.8414 | 1.54 | 4.82 | 447,120.00 | 13.43 | 8.55 | 17.39 | 11.15 | 75.84 | 75.05 | 15.96 | 11.98 | 1.68 | -- | 0.1169 | 91.14 | 15.47 | 9.40 | 18.70 | 5.22 | -4.76 | 4.44 |
| Sysmex Corp | 4.88bn | 531.28m | 19.87bn | 10.04k | 37.10 | 4.49 | 21.84 | 4.07 | 85.64 | 85.64 | 787.09 | 707.21 | 0.8356 | 2.80 | 3.67 | 48,923,520.00 | 9.11 | 8.92 | 11.11 | 11.29 | 53.49 | 52.27 | 10.90 | 11.19 | 2.42 | 9.63 | 0.1119 | 39.12 | 12.43 | 9.47 | 8.42 | 3.79 | 11.61 | 3.71 |
| Fisher & Paykel Healthcare Corporatn Ltd | 1.56bn | 119.02m | 20.28bn | 7.14k | 170.12 | 12.79 | 91.52 | 12.96 | 0.2266 | 0.2266 | 2.97 | 3.01 | 0.777 | 2.04 | 7.33 | 244,055.50 | 5.91 | 16.43 | 6.96 | 19.83 | 59.93 | 62.09 | 7.61 | 19.07 | 0.9987 | 18.03 | 0.0971 | 49.48 | 10.23 | 10.24 | -47.02 | -8.72 | 20.52 | 12.29 |
| Pro Medicus Limited | 166.33m | 82.79m | 23.17bn | 79.00 | 280.37 | 123.35 | 253.80 | 139.31 | 0.7909 | 0.7909 | 1.59 | 1.80 | 0.7239 | 5.79 | 3.72 | -- | 36.03 | 32.19 | 42.01 | 37.84 | 99.82 | 99.58 | 49.78 | 47.15 | 5.98 | 104.83 | 0.0109 | 33.66 | 30.63 | 27.00 | 36.52 | 34.05 | -2.38 | 37.97 |
| Shanghai United Img Hlthcare Co Ltd | 2.32bn | 335.65m | 23.53bn | 7.44k | 69.89 | 5.77 | -- | 10.14 | 1.92 | 1.92 | 13.33 | 23.33 | 0.4349 | 1.14 | 3.17 | 1,469,437.00 | 6.25 | -- | 8.16 | -- | 48.41 | -- | 14.37 | -- | 2.27 | -- | 0.0263 | -- | 23.52 | -- | 19.21 | -- | -- | -- |
| Olympus Corp | 9.68bn | 871.91m | 28.78bn | 28.84k | 32.80 | 4.00 | 18.82 | 2.97 | 74.96 | 64.33 | 829.69 | 614.61 | 0.6525 | 1.69 | 5.76 | 33,760,840.00 | 5.88 | 6.38 | 8.19 | 9.06 | 67.75 | 65.88 | 9.01 | 9.91 | 1.12 | 39.59 | 0.2588 | 21.73 | 6.16 | 3.35 | -80.69 | 26.71 | 1.01 | 19.14 |
| Holder | Shares | % Held |
|---|---|---|
| APG Asset Management NVas of 22 Aug 2024 | 3.27m | 4.99% |
| State Street Global Advisors, Australia, Ltd.as of 26 Jul 2024 | 3.06m | 4.67% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 2.15m | 3.29% |
| First Sentier Investors (Australia) IM Ltd.as of 21 Aug 2024 | 1.37m | 2.10% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 1.35m | 2.06% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.17m | 1.78% |
| First Sentier Investors (UK) IM Ltd.as of 21 Aug 2024 | 1.16m | 1.78% |
| Vanguard Investments Australia Ltd.as of 30 Sep 2024 | 1.02m | 1.56% |
| State Street Global Advisors Trust Co.as of 26 Jul 2024 | 733.02k | 1.12% |
| Geode Capital Management LLCas of 21 Nov 2024 | 652.02k | 1.00% |
